ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Dompé Announces First Patient Enrollment in Novel MOA Trial in Moderate to Severe Dry Eye Disease
June 26, 2019Dompé Farmaceutici and Dompé announced the first patient has been enrolled in Study NGF0118, a multicenter, randomized, double-masked, vehicle-controlled, parallel group study to ... -
Dompé gives the FDA its first approved neurotrophic keratitis treatment
August 27, 2018Milan-based biotech firm Dompé has revealed that the FDA has awarded approval in the US to its Oxervate (cenegermin-bkbj ophthalmic solution) product in the treatment of neurotrophic keratitis (NK).
Pharma Sources Insight January 2025
